Union Minister Dr. Jitendra Singh Launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations
Union Minister Dr. Jitendra Singh launches BIO-NIVESH to connect biotech innovators, investors, industry and government, accelerating investment and scale-up of biotechnology innovations.
- Biotechnology | 09/09/2026 | By News Bureau
Interviews
Harkaran Dhingra, Chief Executive Officer (CEO), DSS Takara Bio India
Precision medicine is redefining healthcare by enabling faster, more accurate and personalised treatment strategies. Harkaran Dhingra, CEO, DSS Takara Bio India, shares with Pharma Industrial India, insights on Indi...
Dr. Abha Doshi, Principal, MET Institute of Pharmacy
As India’s pharmaceutical sector continues to attract global investment, the role of pharmacy education has never been more important. Dr. Abha Doshi, Principal, MET IOP, speaks exclusively with Pharma Industr...
Rishad Dadachanji, Director, Kairish Innotech
Rishad Dadachanji, Director, Kairish Innotech, discusses pharmaceutical automation, engineering excellence, regulatory compliance, and the future of smart manufacturing, in an exclusive interview with Pharma Industr...
Articles
Beyond Manufacturing: Advancing Biopharma Innovation through India-US Strategic Collaboration
India has emerged as a global pharmaceutical manufacturing hub, but transforming into an innovation-led ecosystem will require stronger policy reforms and deeper India-US collaboration...
Building the Future of Pharma with AI CoEs and Predictive Manufacturing
Artificial Intelligence (AI) Centers of Excellence (CoEs), predictive manufacturing, and digital twins are reshaping pharma operations by enabling smarter, connected, and future-ready manufacturing ecosystems....
Why India Must Invest More in Novel Drug Discovery
India’s pharma industry must shift from volume to value by investing in novel drug discovery, innovation, and research and development (R&D) to drive global leadership and sustainable growth....
Blog
Building a Resilient Pharma Supply Chain in India: Challenges, Innovations and the Road Ahead
By Darshana Daga
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
By Pharma Industrial India
Latest news in...
Market
- - HRV Pharma Invests INR 150 Crore to Expand Peptide and High-Potent API Capabilities
- - Aptar and Aceso Therapeutics Partner on Inhaled Antisense Therapy for Cystic Fibrosis
- - Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil
- - Cipla and Qilu Pharmaceutical Partner on Keytruda Biosimilar for US
Next events
Appointments
Saumen Chakraborty, Member Board of Directors, PREMAS BIOTECH
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Silvia Steyrer-Grube, Chief Executive Officer, CEO, Coriolis Pharma
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy